mozavaptan
| SMILES | O=C(N1CCCC(c2c1cccc2)N(C)C)c1ccc(cc1)NC(=O)c1ccccc1C |
| InChIKey | WRNXUQJJCIZICJ-UHFFFAOYSA-N |
Chemical properties
| Hydrogen bond acceptors | 3 |
| Hydrogen bond donors | 1 |
| Rotatable bonds | 4 |
| Molecular weight (Da) | 427.2 |
Drug properties
| Molecular type | Small molecule |
| Endogenous/Surrogate | Surrogate |
| Approved drug | Yes |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| V1B | V1BR | Human | Vasopressin and oxytocin | A | pKi | 4.8 | 4.8 | 4.8 | Guide to Pharmacology |
| V2 | V2R | Human | Vasopressin and oxytocin | A | pKi | 7.4 | 7.75 | 8.1 | Guide to Pharmacology |
| V2 | V2R | Rat | Vasopressin and oxytocin | A | pKi | 7.4 | 7.8 | 8.2 | Guide to Pharmacology |
| V2 | V2R | Human | Vasopressin and oxytocin | A | pKi | 8.01 | 8.02 | 8.03 | ChEMBL |
| OT | OXYR | Human | Vasopressin and oxytocin | A | pKi | 6.18 | 6.18 | 6.18 | ChEMBL |
| V1A | V1AR | Human | Vasopressin and oxytocin | A | pKi | 6.71 | 6.71 | 6.71 | ChEMBL |
| V1B | V1BR | Rat | Vasopressin and oxytocin | A | pKi | 5.0 | 5.0 | 5.0 | PDSP Ki database |
| V1A | V1AR | Rat | Vasopressin and oxytocin | A | pKi | 6.28 | 6.54 | 6.71 | PDSP Ki database |
| V2 | V2R | Rat | Vasopressin and oxytocin | A | pKi | 7.37 | 7.93 | 8.21 | PDSP Ki database |
| OT | OXYR | Rat | Vasopressin and oxytocin | A | pKi | 5.81 | 5.81 | 5.81 | PDSP Ki database |
| V1A | V1AR | Human | Vasopressin and oxytocin | A | pKi | 6.82 | 6.82 | 6.82 | PDSP Ki database |
| V2 | V2R | Human | Vasopressin and oxytocin | A | pKi | 8.03 | 8.03 | 8.03 | PDSP Ki database |
| V1A | V1AR | Human | Vasopressin and oxytocin | A | pKi | 8.17 | 8.17 | 8.17 | Drug Central |
| V1B | V1BR | Human | Vasopressin and oxytocin | A | pKi | 8.32 | 8.32 | 8.32 | Drug Central |
| V2 | V2R | Human | Vasopressin and oxytocin | A | pKi | 8.1 | 8.1 | 8.1 | Drug Central |
| OT | OXYR | Human | Vasopressin and oxytocin | A | pKi | 8.21 | 8.21 | 8.21 | Drug Central |
| V1A | V1AR | Human | Vasopressin and oxytocin | A | pKi | 6.8 | 6.95 | 7.1 | Guide to Pharmacology |
| V1B | V1BR | Human | Vasopressin and oxytocin | A | pKi | 5.0 | 5.0 | 5.0 | PDSP Ki database |
| V1A | V1AR | Rat | Vasopressin and oxytocin | A | pKi | 6.3 | 6.3 | 6.3 | Guide to Pharmacology |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| V2 | V2R | Rat | Vasopressin and oxytocin | A | pIC50 | 6.52 | 7.22 | 7.92 | ChEMBL |
| V2 | V2R | Human | Vasopressin and oxytocin | A | pIC50 | 6.3 | 6.3 | 6.3 | ChEMBL |
| V1A | V1AR | Rat | Vasopressin and oxytocin | A | pIC50 | 8.23 | 8.23 | 8.23 | Drug Central |
| V2 | V2R | Rat | Vasopressin and oxytocin | A | pIC50 | 8.1 | 8.1 | 8.1 | Drug Central |
| V1A | V1AR | Rat | Vasopressin and oxytocin | A | pIC50 | 5.85 | 5.85 | 5.85 | ChEMBL |